08:48 AM EDT, 07/02/2024 (MT Newswires) -- Koru Medical Systems ( KRMD ) said Tuesday that its FreedomEdge System has received regulatory clearance in Japan.

The FreedomEdge System is designed for the subcutaneous delivery of multiple drugs, including CSL Behring's Hizentra subcutaneous immunoglobulin, Takeda Pharmaceutical's ( TAK ) Cuvitru, and Sobi's Aspaveli paroxysmal nocturnal hemoglobinuria.

Shares of the company were up 3.4% in recent premarket activity.

Price: 2.4300, Change: +0.08, Percent Change: +3.40